Fernando Corrales-Medina

Medicine & Life Sciences

1. Pediatrics 100%
2. Carotid Intima-Media Thickness 66%
3. Menorrhagia 52%
4. Hemophilia A 49%
5. BAX 855 43%
6. Venous Thromboembolism 43%
7. Child 40%
8. marizomib 37%
9. Metabolic Syndrome 36%
10. Liver Transplantation 36%
11. Kaposiform Hemangioendothelioma 34%
12. Hypertension 34%
13. Population 34%
14. Abdominal obesity metabolic syndrome 34%
15. Peru 33%
16. Kasabach-Merritt Syndrome 32%
17. Prune Belly Syndrome 32%
18. Panobinostat 32%
19. Thrombocytopenia 30%
20. Iron-Deficiency Anemias 27%
21. Hepatoblastoma 27%
22. Intracranial Thrombosis 26%
23. Equivalence Trials 26%
24. Dabigatran 26%
25. Theranostic Nanomedicine 26%
26. Carotid Artery Diseases 26%
27. Coronavirus 25%
28. Bortezomib 24%
29. Clinical Trials, Phase I 24%
30. Neoplasms 24%
31. fibrin fragment D 23%
32. Retinoblastoma 23%
33. Pericardial Effusion 23%
34. Drug Therapy 23%
35. Vascular Diseases 23%
36. Prothrombin Time 22%
37. High-Throughput Nucleotide Sequencing 22%
38. Leukopenia 21%
39. Sickle Cell Anemia 21%
40. Acute Disease 21%
41. Hemostatics 21%
42. Hemorrhage 21%
43. Osteosarcoma 20%
44. Therapeutics 20%
45. Hematopoietic Stem Cells 19%
46. Carotid Arteries 19%
47. Nitric Oxide Synthase 19%